hATTR polyneuropathy in Russia

Trial Identifier:	D8450R00005
Sponsor:	AstraZeneca
Start Date:	December 2023
Primary Completion Date:	May 2024
Study Completion Date:	May 2024

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
Russia	Kazan, Russia
Russia	Moscow, Russia
Russia	Saint-Petersburg, Russia, 194354

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.